NO994626L - Substituerte benzamider - Google Patents

Substituerte benzamider

Info

Publication number
NO994626L
NO994626L NO994626A NO994626A NO994626L NO 994626 L NO994626 L NO 994626L NO 994626 A NO994626 A NO 994626A NO 994626 A NO994626 A NO 994626A NO 994626 L NO994626 L NO 994626L
Authority
NO
Norway
Prior art keywords
substituted benzamides
benzamides
substituted
Prior art date
Application number
NO994626A
Other languages
English (en)
Other versions
NO312671B1 (no
NO994626D0 (no
Inventor
Tieno Germann
Stefanie Frosch
Oswald Zimmer
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of NO994626D0 publication Critical patent/NO994626D0/no
Publication of NO994626L publication Critical patent/NO994626L/no
Publication of NO312671B1 publication Critical patent/NO312671B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94—Oxygen atom, e.g. piperidine N-oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO19994626A 1998-09-24 1999-09-23 Substituerte benzamider, farmasöytiske preparater inneholdende disse samt anvendelsen av disse for fremstilling avlegemidler NO312671B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843793A DE19843793C2 (de) 1998-09-24 1998-09-24 Substituierte Benzamide

Publications (3)

Publication Number Publication Date
NO994626D0 NO994626D0 (no) 1999-09-23
NO994626L true NO994626L (no) 2000-03-27
NO312671B1 NO312671B1 (no) 2002-06-17

Family

ID=7882078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994626A NO312671B1 (no) 1998-09-24 1999-09-23 Substituerte benzamider, farmasöytiske preparater inneholdende disse samt anvendelsen av disse for fremstilling avlegemidler

Country Status (26)

Country Link
US (1) US6080742A (no)
EP (1) EP0989121B1 (no)
JP (1) JP2000095761A (no)
KR (1) KR20000023339A (no)
CN (1) CN1126741C (no)
AR (1) AR021814A1 (no)
AT (1) ATE309987T1 (no)
AU (1) AU750919B2 (no)
BR (1) BR9906070A (no)
CA (1) CA2283021A1 (no)
CO (1) CO5160263A1 (no)
CZ (1) CZ295496B6 (no)
DE (2) DE19843793C2 (no)
DK (1) DK0989121T3 (no)
ES (1) ES2251143T3 (no)
HU (1) HUP9903216A3 (no)
IL (1) IL132012A (no)
NO (1) NO312671B1 (no)
NZ (1) NZ337531A (no)
PE (1) PE20001050A1 (no)
PL (1) PL194897B1 (no)
RU (1) RU2221783C2 (no)
SI (1) SI0989121T1 (no)
SK (1) SK283316B6 (no)
UY (1) UY25712A1 (no)
ZA (1) ZA996133B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10002509A1 (de) 2000-01-21 2001-07-26 Gruenenthal Gmbh Substituierte Glutarimide
AU2001252196A1 (en) * 2000-03-20 2001-10-03 Grunenthal G.M.B.H. Substituted benzamides
US20050201981A1 (en) * 2004-03-10 2005-09-15 Chih-Ping Liu Method of optimizing treatment with interferon-tau
US20050118138A1 (en) * 2000-07-19 2005-06-02 Chih-Ping Liu Method of treatment using interferon-tau
US20050084478A1 (en) * 2000-10-17 2005-04-21 Chih-Ping Liu Combination therapy using interferon-tau
US7431920B2 (en) * 2000-07-19 2008-10-07 Pepgen Corporation Method of treating IL-10 deficiency
US20050226845A1 (en) * 2004-03-10 2005-10-13 Chih-Ping Liu Method of treatment using interferon-tau
US20040247565A1 (en) * 2000-07-19 2004-12-09 Chih-Ping Liu Method of treatment using interferon-tau
US20050118137A1 (en) * 2000-07-19 2005-06-02 Chih-Ping Liu Method of treatment using interferon-tau
EP1199074A1 (en) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
EP1188438A1 (en) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
JP4361273B2 (ja) * 2001-02-27 2009-11-11 アメリカ合衆国 潜在的な血管形成阻害剤としてのサリドマイド類似体
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
WO2003037365A1 (en) * 2001-11-01 2003-05-08 The Johns Hopkins University Methods and compositions for treating vascular leak using hepatocyte growth factor
DE10163595A1 (de) * 2001-12-21 2003-08-07 Gruenenthal Gmbh In 3-Position heterocyclisch substituierte Piperidin-2,6-dione
CA2808646C (en) 2003-09-17 2016-08-23 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Thalidomide analogs as tnf-alpha modulators
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
US20060078942A1 (en) * 2004-03-10 2006-04-13 Pepgen Corporation Method of treatment using interferon-tau
US20080025948A1 (en) * 2004-03-10 2008-01-31 Chih-Ping Liu Methods of Treatment Using Interferon-Tau
DE102004026703A1 (de) * 2004-05-28 2005-12-29 Grünenthal GmbH Verfahren zur Herstellung von in 3-Position heterocyclisch substituierten Piperidin-2,6-dionen
EP2004614B1 (en) * 2006-04-13 2016-10-19 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Tetrahalogenated compounds useful as inhibitors of angiogenesis
WO2009132136A1 (en) 2008-04-23 2009-10-29 Rigel Pharmaceuticals, Inc. Carboxamide compounds for the treatment of metabolic disorders
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
KR102316961B1 (ko) * 2020-01-29 2021-10-26 프라비바이오 주식회사 면역억제제로서의 벤젠 유도체의 면역억제용 약학적 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545672B2 (de) * 1965-05-08 1974-11-07 Chemie Gruenenthal Gmbh, 5190 Stolberg Dikarbonsäureimidderivate und Verfahren zu ihrer Herstellung
GB8928043D0 (en) * 1989-12-12 1990-02-14 Pfizer Ltd Muscarinic receptor antagonists

Also Published As

Publication number Publication date
PE20001050A1 (es) 2000-11-18
RU2221783C2 (ru) 2004-01-20
HUP9903216A2 (hu) 2000-06-28
NO312671B1 (no) 2002-06-17
DE19843793A1 (de) 2000-04-20
JP2000095761A (ja) 2000-04-04
ZA996133B (en) 2000-04-06
PL194897B1 (pl) 2007-07-31
SK130899A3 (en) 2000-06-12
IL132012A (en) 2004-02-19
IL132012A0 (en) 2001-03-19
DE59912795D1 (de) 2005-12-22
DE19843793C2 (de) 2000-08-03
HU9903216D0 (en) 1999-11-29
CO5160263A1 (es) 2002-05-30
CA2283021A1 (en) 2000-03-24
EP0989121B1 (de) 2005-11-16
EP0989121A1 (de) 2000-03-29
NO994626D0 (no) 1999-09-23
AR021814A1 (es) 2002-08-07
ATE309987T1 (de) 2005-12-15
AU4886199A (en) 2000-03-30
SI0989121T1 (sl) 2006-04-30
ES2251143T3 (es) 2006-04-16
US6080742A (en) 2000-06-27
BR9906070A (pt) 2000-08-15
DK0989121T3 (da) 2005-12-12
CN1250048A (zh) 2000-04-12
NZ337531A (en) 2000-09-29
PL335555A1 (en) 2000-03-27
CN1126741C (zh) 2003-11-05
CZ295496B6 (cs) 2005-08-17
HK1026211A1 (en) 2000-12-08
CZ338699A3 (cs) 2000-08-16
UY25712A1 (es) 2001-05-31
SK283316B6 (sk) 2003-05-02
AU750919B2 (en) 2002-08-01
KR20000023339A (ko) 2000-04-25
HUP9903216A3 (en) 2000-10-30

Similar Documents

Publication Publication Date Title
ATE341990T1 (de) Sigmidoskop
DE69904211D1 (de) Polyalkoxylierte naphtopyrans
ID23211A (id) Sulfanilsilana
DE59912371D1 (de) Gleitschalungsfertiger
DE59902874D1 (de) Buchsenkontakt
NO994626D0 (no) Substituerte benzamider
DE59907306D1 (de) Fadenchangierung
ID23287A (id) Trisiklik tersubstitusi
EP1124578A4 (en) NEW IMMUNOADJUVANTS
DE59906931D1 (de) Exzenterzahnradgetriebe
DE59911683D1 (de) Fahrzeugschliessanlage
DE69939653D1 (de) Erkstoff
DE59908968D1 (de) Benzoylpyridazine
ID23219A (id) Trisiklik tersubstitusi
DE59913393D1 (de) Fadenchangierung
DK0969233T3 (da) Strömningsbegrænser
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
DE59908057D1 (de) Underdruckhandhabungseinrichung
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE59808995D1 (de) Endomikroskopsystem
DE59807217D1 (de) Nadellager
FI980759A0 (fi) Taetningskonstruktion foer suglaodan i en sugvals
DE19842103B4 (de) Stanznietzuführung
DE69935559D1 (de) Bussignalleitungstreiber
DE59911610D1 (de) Substituierte benzoylcyclohexandione

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees